Lactobacillus rhamnosus LRa05 on glycemic control and gut microbiota in patients with type 2 diabetes

Figure 6 Changes in the abundance of specific genera in the LRa05 and placebo groups. A: Relative abundance of Ruthonibacterium across Placebo_B and LRa05_B groups; B: Relative abundance of Faecalibacterium, Prevotella, and Butyricimomas across Placebo_A and Placebo_B groups; C: Relative abundance of various bacterial taxa across LRa05_A and LRa05_B groups.